OPK News and Press, Opko Health Inc. From 01/04/24

MIAMI, Jan. 04, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (the “ Company ”) today announced the pricing of its private offering of $200.0 million aggregate principal amount of its Convertible Senior Notes due 2029 (the “ Notes ”). The Company...

2024-01-04 12:34:16 ET More on Mid-day movers & Stocks. Relmada Therapeutics, Inc. (RLMD) Q3 2023 Earnings Call Transcript Relmada And REL-1017: Intriguing Underlying Efficacy In MDD Ahead Of Eventful 2024 Avenue Therapeutics GAAP EPS of $0.06 beats by $0.32 ...

2024-01-04 10:00:14 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...

2024-01-03 17:10:54 ET More on OPKO Health OPKO Health: FDA Approval To Save The Company Seeking Alpha’s Quant Rating on OPKO Health Historical earnings data for OPKO Health For further details see: OPKO Health commences private offering of convert...

MIAMI, Jan. 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (the “ Company ”) today announced that it is commencing a private offering of $200.0 million aggregate principal amount of its Convertible Senior Notes due 2029 (the “ Notes ”). The Co...

2023-12-27 12:29:36 ET More on AbbVie, Johnson & Johnson, etc. Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) AbbVie Vs. GSK: Dual Dominance In Pharma ...

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing PR Newswire ELMWOOD PARK, N.J. , Nov. 28, 2023 /PRNewswire/ -- BioReference ® Health, LLC (BRH), a leading specialty laboratory in the United States , announ...

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™ PR Newswire World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON and ELMWOOD PAR...

2023-11-06 19:32:06 ET OPKO Health, Inc. (OPK) Q3 2023 Earnings Conference Call November 06, 2023, 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman and Chief Executive Officer Elias Zerhouni - President and Vice Chai...

2023-11-06 16:08:44 ET More on OPKO Health OPKO Health: FDA Approval To Save The Company Earnings week ahead: Disney, AMC, Plug Power, Lucid, Realty Income and more Biggest stock movers today: Walgreens Boots Alliance, Nike, Editas Medicine and more Seeking A...